Ja Hyeon Ku - Publications, H-index & Citations

Ja Hyeon Ku

seoul national university (snu)

46H指数

553论文数

9.6K被引数

收录论文 149

发表时间

The staging of re-TURB is crucial in predicting the response to BCG therapy in patients with T1 high-grade bladder cancer

INVESTIGATIVE AND CLINICAL UROLOGY

IF2.1

2025-11-01

OAAI

Lee, Hyomyoung; So, Sang Won; Han, Jang Hee; Yuk, Hyeong Dong; Jeong, Chang Wook; Ku, Ja Hyeon; Kwak, Cheol; Jeong, Seung-hwan

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer ctDNA指导下的辅助阿特珠单抗治疗在肌肉浸润性膀胱癌中的应用

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2025-10-01

PREAI

Powles, Thomas; Kann, Ariel G.; Castellano, Daniel; Gross-Goupil, Marine; Nishiyama, Hiroyuki; Bracarda, Sergio; Bjerggaard Jensen, Jorgen; Makaroff, Lydia; Jiang, Shusuan; Ku, Ja Hyeon; Park, Se Hoon; Reig Torras, Oscar; Ye, Dingwei; Maruzzo, Marco; Necchi, Andrea; Morales-Barrera, Rafael; Giunta, Emilio Francesco; Lee, Jae Lyun; Tortora, Giampaolo; Urun, Yuksel; Dolowy, Lukasz; Erdem, Dilek; Pinto, Alvaro; Grando, Fabricio; Zou, Wei; Assaf, Zoe June; Vuky, Jacqueline; Degaonkar, Viraj; Steinberg, Elizabeth E.; Bellmunt, Joaquim; Gschwend, Jurgen E.

TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trial TAR-200联合西特雷利单抗与西特雷利单抗单药治疗作为不适合或拒绝新辅助顺铂为基础化疗的肌层浸润性膀胱癌患者的新辅助治疗（SunRISe-4）：一项随机、开放标签Ⅱ期试验的期中分析

lancet oncology

IF0

2025-08-27

PREAI

Andrea Necchi; Félix Guerrero-Ramos; Paul L Crispen; Bernardo Herrera-Imbroda; Rohan Garje; Thomas Powles; Charles C Peyton; Benjamin Pradere; Ja Hyeon Ku; Neal Shore; Martin Bögemann; Mark A Preston; Evanguelos Xylinas; Cristina Sanchez de Llano; Mohamad Hasan; Hind Stitou; Sumeet Bhanvadia; Hussein Sweiti; Sarah P Psutka

High carbohydrate antigen 19–9 levels indicate poor prognosis in patients with bladder cancer following radical cystectomy 高碳水化合物抗原19–9水平提示膀胱癌根治性膀胱切除术后患者预后不良。

Frontiers in Oncology

IF3.3

2025-08-23

OAAI

Sang Won So; Jang Hee Han; Hyeong Dong Yuk; Chang Wook Jeong; Cheol Kwak; Ja Hyeon Ku; Seung-hwan Jeong

Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial 作者更正: Sasanlimab加BCG在BCG幼稚，高危非肌层浸润性膀胱癌中的应用: 随机3期CREST试验

Nature Medicine

IF50

2025-07-21

OAAI

Neal D. Shore; Thomas B. Powles; Jens Bedke; Matthew D. Galsky; Joan Palou Redorta; Ja Hyeon Ku; Michal Kretkowski; Evanguelos Xylinas; Boris Alekseev; Dingwei Ye; Félix Guerrero-Ramos; Alberto Briganti; Girish S. Kulkarni; Julia Brinkmann; Anna-Maria Calella; Rossano Cesari; Anthony Eccleston; Elisabete Michelon; Jennifer Vermette; Caimiao Wei; Gary D. Steinberg

Fully automated segmentation and classification of renal tumors on CT scans via machine learning 基于机器学习的CT图像肾肿瘤全自动分割与分类

BMC CANCER

IF3.4

2025-01-29

OAAI

Han, Jang Hee; Kim, Byung Woo; Kim, Taek Min; Ko, Ji Yeon; Choi, Seung Jae; Kang, Minho; Kim, Sang Youn; Cho, Jeong Yeon; Ku, Ja Hyeon; Kwak, Cheol; Kim, Young-Gon; Jeong, Chang Wook

Anesthetic approaches and 2-year recurrence rates in non-muscle invasive bladder cancer: a randomized clinical trial

REGIONAL ANESTHESIA AND PAIN MEDICINE

IF3.5

2024-12-31

PREAI

Han, Jang Hee; Yuk, Hyeong Dong; Jeong, Seung-Hwan; Jeong, Chang Wook; Kwak, Cheol; Kim, Jin-Tae; Ku, Ja Hyeon

Beta-human chorionic gonadotropin, carbohydrate antigen 19-9, cancer antigen 125, and carcinoembryonic antigen as prognostic and predictive biological markers in bladder cancer

FRONTIERS IN ONCOLOGY

IF3.3

2024-12-23

OAAI

Yuk, Hyeong Dong; Han, Jang Hee; Jeong, Seung-Hwan; Jeong, Chang Wook; Kwak, Cheol; Ku, Ja Hyeon

Highly efficient nucleic acid encapsulation method for targeted gene therapy using antibody conjugation system

MOLECULAR THERAPY NUCLEIC ACIDS

IF6.1

2024-12-01

OAAI

Hong, Seokbong; Jeong, Seung-hwan; Han, Jang Hee; Yuk, Hyeong Dong; Jeong, Chang Wook; Ku, Ja Hyeon; Kwak, Cheol

Urine-based molecular testing identifies FGFR alteration-positive patients for treatment with TAR-210 尿液分子检测可识别FGFR突变阳性的患者，以进行TAR-210治疗

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Guerrero-Ramos, F.; Ku, J. H.; Vilaseca, A.; Raventos, C. X.; Shore, N. D.; Meeks, J.; Li, R.; Daneshmand, S.; Jayram, G.; Kang, T. W.; Beeharry, N.; Zhang, J.; Weingeist, D.; Smirnov, D. A.; Brunton, B.; Cost, C.; Kalota, A.; Lauring, J.; Stone, N.; Thomas, S.

Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma

EXPERIMENTAL AND MOLECULAR MEDICINE

IF12.9

2024-08-01

OAAI

Lee, Cho-Rong; Suh, Jungyo; Jang, Dongjun; Jin, Bo-Yeong; Cho, Jaeso; Lee, Moses; Sim, Hyungtai; Kang, Minyong; Lee, Jueun; Park, Ju Hyun; Lee, Kyoung-Hwa; Hwang, Geum-Sook; Moon, Kyung Chul; Song, Cheryn; Ku, Ja Hyeon; Kwak, Cheol; Kim, Hyeon Hoe; Cho, Sung-Yup; Choi, Murim; Jeong, Chang Wook

Preoperative smoking and robot-assisted radical cystectomy outcomes & complications in multicenter KORARC database 多中心KORARC数据库中的术前吸烟和机器人辅助根治性膀胱切除术结果和并发症

SCIENTIFIC REPORTS

IF3.9

2024-05-08

OAAI

Choi, Joongwon; Lee, Jooyoung; Hwang, Yu Been; Jeong, Byong Chang; Lee, Sangchul; Ku, Ja Hyeon; Nam, Jong Kil; Kim, Wansuk; Lee, Ji Youl; Hong, Sung Hoo; Rha, Koon Ho; Han, Woong Kyu; Ham, Won Sik; Kang, Sung Gu; Kang, Seok Ho; Oh, Jong Jin; Lee, Young Goo; Kwon, Tae Gyun; Kim, Tae-Hwan; Jeon, Seung Hyun; Lee, Sang Hyub; Park, Sung Yul; Yoon, Young Eun; Lee, Yong Seong

A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron

NATURE IMMUNOLOGY

IF27.6

2024-04-25

PREAI

Sharma, Garima; Sharma, Amit; Kim, Inhae; Cha, Dong Gon; Kim, Somi; Park, Eun Seo; Noh, Jae Gyun; Lee, Juhee; Ku, Ja Hyeon; Choi, Yoon Ha; Kong, Jungho; Lee, Haena; Ko, Haeun; Lee, Juhun; Notaro, Anna; Hong, Seol Hee; Rhee, Joon Haeng; Kim, Sang Geon; De Castro, Cristina; Molinaro, Antonio; Shin, Kunyoo; Kim, Sanguk; Kim, Jong Kyoung; Rudra, Dipayan; Im, Sin-Hyeog

CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer CREST: sasanlimab和卡介苗对卡介苗-幼稚高危非肌肉浸润性膀胱癌患者的III期研究

FUTURE ONCOLOGY

IF2.6

2024-01-08

OAAI

Steinberg, Gary D.; Shore, Neal D.; Redorta, Joan Palou; Galsky, Matthew D.; Bedke, Jens; Ku, Ja Hyeon; Kretkowski, Michal; Hu, Hailong; Penkov, Konstantin; Vermette, Jennifer J.; Tarazi, Jamal C.; Randall, Alison E.; Pierce, Kristen J.; Saltzstein, Daniel; Powles, Thomas B.

Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2023-11-23

PREAI

Loriot, Yohann; Matsubara, Nobuaki; Park, Se Hoon; Huddart, Robert A.; Burgess, Earle F.; Houede, Nadine; Banek, Severine; Guadalupi, Valentina; Ku, Ja Hyeon; Valderrama, Begona P.; Tran, Ben; Triantos, Spyros; Kean, Yin; Akapame, Sydney; Deprince, Kris; Mukhopadhyay, Sutapa; Stone, Nicole L.; Siefker-Radtke, Arlene O.

Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2023-11-09

148

PREAI

van der Heijden, M. S.; Sonpavde, G.; Powles, T.; Necchi, A.; Burotto, M.; Schenker, M.; Sade, J. P.; Bamias, A.; Beuzeboc, P.; Bedke, J.; Oldenburg, J.; Chatta, G.; Urun, Y.; Ye, D.; He, Z.; Valderrama, B. P.; Ku, J. H.; Tomita, Y.; Filian, J.; Wang, L.; Purcea, D.; Patel, M. Y.; Nasroulah, F.; Galsky, M. D.

Asian subgroup analysis of the THOR phase III study: Erdafitinib versus chemotherapy in patients with advanced or metastatic urothelial cancer and selected fibroblast growth factor receptor alterations

ANNALS OF ONCOLOGY

IF65.4

2023-11-01

PREAI

Matsubara, N.; Loriot, Y.; Burgess, E. F.; Park, S. H.; Huddart, R. A.; Ku, J. H.; Tran, B.; Triantos, S.; Deprince, K.; Mukhopadhyay, S.; Hemaya, R.; Zhuo, J.; Siefker-Radtke, A. O.

First safety and efficacy results of the TAR-210 erdafitinib (erda) intravesical delivery system in patients (pts) with non emuscle-invasive bladder cancer (NMIBC) with select FGFR alterations (alt)

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Vilaseca, A.; Jayram, G.; Raventos, C.; Shore, N. D.; Zainfeld, D.; Kang, T. W.; Ku, J. H.; Meeks, J.; Faba, O. Rodriguez; Roghmann, F.; Daneshmand, S.; Beeharry, N.; Cost, C.; Kalota, A.; Lauring, J.; Peterson, M.; Quiroz, M.; Stone, N.; Zhu, W.; Guerrero-Ramos, F.

Erdafitinib (erda) vs chemotherapy (chemo) in patients (pts) with advanced or metastatic urothelial cancer (mUC) with select FGFR alterations (FGFRalt): Subgroups from the phase III THOR study

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Loriot, Y.; Matsubara, N.; Huddart, R. A.; Houede, N.; Laguerre, B.; Guadalupi, V.; Ku, J. H.; Triantos, S.; Akapame, S.; Deprince, K.; Mukhopadhyay, S.; Siefker-Radtke, A. O.

Role of lymphatic invasion in predicting biochemical recurrence after radical prostatectomy 淋巴管浸润在预测前列腺癌根治术后生化复发中的作用

FRONTIERS IN ONCOLOGY

IF3.3

2023-09-11

OAAI

Chung, Dae Hyuk; Han, Jang Hee; Jeong, Seung-Hwan; Yuk, Hyeong Dong; Jeong, Chang Wook; Ku, Ja Hyeon; Kwak, Cheol

研究方向